StemCells, Inc. Posts Letter to Shareholders
29 mai 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted...
StemCells, Inc. Advances Clinical Trial in Age-Related Macular Degeneration to Final Cohort
22 mai 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has transplanted the Company's proprietary HuCNS-SC® (purified human neural stem cells)...
StemCells, Inc. Provides Update on Its Phase I/II Study in Spinal Cord Injury
19 mai 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Armin Curt, M.D., study principal investigator, presented an interim update on the Phase I/II trial...
StemCells, Inc. Reports First Quarter 2014 Financial Results and Provides Business Update
14 mai 2014 16h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss First Quarter 2014 Financial Results
01 mai 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Completes Enrollment in Spinal Cord Injury Trial
17 avr. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal cord injury. The...
StemCells, Inc. to Participate at the 13th Annual Needham Healthcare Conference
19 mars 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 13th Annual Needham Healthcare Conference, on Wednesday, April 9,...
StemCells, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business Update
12 mars 2014 15h30 HE
|
StemCells, Inc.
NEWARK, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to Participate at 2014 Regen Med Investor Day in New York
10 mars 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn will present at the 2nd Annual Regen Med Investor Day, Wednesday, March 26, 2014,...
StemCells, Inc. Announces Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results
05 mars 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...